Olive Fruit Extract Standardization for Visceral Fat Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current studies on hydroxytyrosol consumption have yielded inconsistent results regarding its effectiveness in reducing body-mass index and visceral fat, with no significant changes observed in body composition parameters or weight loss in previous clinical trials.
Innovation Solution
A daily dose of 15 to 20 mg of hydroxytyrosol from olive fruit extract, standardized to ensure consistent polyphenol content and antioxidant activity, is administered orally to overweight subjects in a controlled clinical trial to assess its impact on body-mass index and visceral fat reduction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If hydroxytyrosol is administered at low doses (5-25 mg/day) in clinical studies, then antioxidant effects and cardiovascular protection are observed, but no significant changes in body composition parameters and body weight are achieved
Solution Approach 1:
The patent changes the dosage parameter from the conventional low doses (5-25 mg/day) used in previous studies to a higher dose range (15-20 mg/day of standardized olive fruit extract containing hydroxytyrosol). This parameter change is intended to overcome the limitation of previous studies that used insufficient doses to achieve both antioxidant effects and body composition changes.
Solution Approach 2:
The patent uses a standardized olive fruit extract composition that contains hydroxytyrosol along with other polyphenolic compounds (oleuropein, tyrosol, and related secoiridoid glycosides). This composite approach leverages the synergistic effects of multiple compounds rather than isolating hydroxytyrosol alone, thereby achieving both antioxidant protection and significant body weight reduction at the proposed dose.
2Measurement precision
If olive fruit extract is standardized to ensure consistent polyphenol content, then reproducible antioxidant activity is achieved, but manufacturing complexity increases
Solution Approach 1:
The patent establishes specific standardized parameters for the olive fruit extract: hydroxytyrosol content of 15-20 mg/day, total polyphenols of 60-80 mg/day, and antioxidant activity (ORAC) of 80-100 μg/mL. By defining these quantitative parameters, the patent ensures batch-to-batch consistency in polyphenol content and antioxidant activity, making the extract reproducible for clinical applications while providing clear manufacturing targets.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The 15 mg daily dose of hydroxytyrosol significantly reduces body weight, body-mass index, and visceral fat in overweight women, with noticeable effects starting from the first month and increasing through the six-month study period, while lower doses do not show significant effects compared to a placebo.
Implementation Method 1
Hydroxytyrosol is considered one of the most powerful scavengers of free radicals, reducing oxidative stress, flaccidity, age spots, and skin aging
Implementation Method 2
the administration of an olive fruit extract comprising hydroxytyrosol (HT) in a significant amount reduces the body-mass index and/or visceral fat
Data Source
AI summary
The present invention concerns the use of olive fruit extract in the reduction of body- mass index and visceral fat in overweight subjects. A study has, in particular, shown that with the administration of an olive fruit extract with a daily dose of at least 10 mg hydroxytyrosol, the body-mass index and visceral fat can be reduced in overweight subjects, in particular women.